Profile
Torsten Meldgaard Madsen worked as Divisional Director-Brintellix Science Team at H.
Lundbeck A from 2009 to 2013.
From 2014 to 2015, worked as Chief Medical Officer & Vice President at Lundbeck, Inc. From 2015 to 2019, worked as Chief Medical Officer at Aptinyx, Inc. From 2020 to 2025, worked as Chief Executive Officer at Hoba Therapeutics ApS.
Education includes a doctorate from the University of Copenhagen.
Former positions of Torsten Meldgaard Madsen
| Companies | Position | End |
|---|---|---|
Hoba Therapeutics ApS
Hoba Therapeutics ApS BiotechnologyHealth Technology Engages in research and development of therapeutics for pain, hearing loss and sensory neuron disorders | Chief Executive Officer | 2025-08-31 |
| APTINYX | Chief Tech/Sci/R&D Officer | 2019-03-14 |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Chief Tech/Sci/R&D Officer | 2015-03-31 |
| H. LUNDBECK A/S | Corporate Officer/Principal | 2012-12-31 |
Training of Torsten Meldgaard Madsen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
H. Lundbeck A/S
H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Health Technology |
Aptinyx, Inc.
Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Hoba Therapeutics ApS
Hoba Therapeutics ApS BiotechnologyHealth Technology Engages in research and development of therapeutics for pain, hearing loss and sensory neuron disorders | Health Technology |
- Stock Market
- Insiders
- Torsten Meldgaard Madsen
















